(Q22242347)

PubMed

28 March 2023

Sue Irwin

series ordinal

2

author given names

Sue

author last names

Irwin

1 reference

PubMed

28 March 2023

Gordon R. Greenberg

series ordinal

3

author given names

Gordon R

author last names

Greenberg

1 reference

PubMed

The American Journal of Gastroenterology

28 March 2023

language of work or name

English

0 references

publication date

September 2005

0 references

published in

0 references

volume

100

0 references

issue

9

0 references

page(s)

2031-2035

0 references

cites work

Bone loss. Factors that regulate osteoclast differentiation: an update

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2005.50219.X

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2005.50219.X

Infliximab maintenance therapy for fistulizing Crohn's disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2005.50219.X

RANK-L and RANK: T cells, bone loss, and mammalian evolution

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1572-0241.2005.50219.X

Evaluation of bone mineral density in inflammatory bowel disease: current safety focus

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Glucocorticoid osteoporosis--mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Fracture risk is increased in Crohn's disease, but not in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

The association between corticosteroid use and development of fractures among IBD patients in a population-based database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.50219.X

10.1111/J.1572-0241.2005.50219.X

21 January 2018

Identifiers

DOI

0 references